文献
J-GLOBAL ID:201102229879338856
整理番号:11A1128734
HER2陽性進行性胃癌または,胃食道接合部癌(ToGA)の治療のための化学療法併用トラスツズマブと化学療法単独の比較:第3相,非盲検,無作為対照試験
Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): A phase 3, open-label, randomised controlled trial
著者 (16件):
BANG Y.-J.
(Seoul National Univ. Coll. of Medicine, Seoul, KOR)
,
VAN CUTSEM E.
(Univ. Hospital Gasthuisberg, Leuven, BEL)
,
FEYEREISLOVA A.
(F Hoffmann-La Roche, Basel, CHE)
,
LEHLE M.
(F Hoffmann-La Roche, Basel, CHE)
,
CHUNG H.C.
(Yonsei Univ. Coll. of Medicine, Seoul, KOR)
,
SHEN L.
(Peking Univ., Beijing, CHN)
,
SAWAKI A.
(Aichi Cancer Center, Aichi, JPN)
,
LORDICK F.
(Nationales Centrum fuer Tumorerkrankungen, Heidelberg, DEU)
,
OHTSU A.
(National Cancer Center, Kashiwa, JPN)
,
OMURO Y.
(Komagome General Hospital, Tokyo, JPN)
,
SATOH T.
(Kinki Univ. School of Medicine, Osaka, JPN)
,
APRILE G.
(Azienda Ospedaliero-Universitaria, Udine, ITA)
,
KULIKOV E.
(Regional Clinical Oncology Dispensary, Ryazan, RUS)
,
HILL J.
(Roche Products, NSW, AUS)
,
RUSCHOFF J.
(Targos Molecular Pathology, Kassel, DEU)
,
KANG Y.-K.
(Asan Medical Centre, Seoul, KOR)
資料名:
Lancet
(Lancet)
巻:
376
号:
9742
ページ:
687-697
発行年:
2010年
JST資料番号:
B0673A
ISSN:
0140-6736
CODEN:
LANCA
資料種別:
逐次刊行物 (A)
発行国:
オランダ (NLD)
言語:
英語 (EN)